ArticleTransboundary and emerging diseases2025
Assessment of Foot-and-Mouth Disease Trends in Türkiye Between 2005 and 2025.
Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Serological Detection of O-Type and A-Type Antibodies Against Foot-and-Mouth Disease in Tongliao City, 2021-2022.Veterinary medicine international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foot-and-mouth disease (FMD) is a highly contagious viral illness that continues to threaten livestock health, productivity, and trade, particularly in countries like Türkiye where multiple FMD serotypes cocirculate. This study aimed to analyze the temporal and spatial distributions, serotype dynamics, and seasonal patterns of FMD in Türkiye between 2005 and 2025. The geographical distribution of national FMD surveillance data spanning 2005-2025 was analyzed, together with a time series analysis to evaluate trends and seasonality in the number of FMD-reported outbreaks (number of villages affected by FMD outbreaks). Additionally, event-driven outbreaks were assessed by analyzing the number of reported outbreaks when a serotype introduction occurred and during Kurban Bayramı festivities. The results showed that the number of FMD-reported outbreaks peaked between 2010 and 2016, with serotype O accounting for the majority of reported outbreaks. A decline in outbreaks followed, likely attributable to expanded vaccination coverage, improved diagnostic capacity, and the implementation of targeted control measures. Seasonal patterns indicated a higher concentration of outbreaks during the spring months. Furthermore, it was noted that introductions of serotypes, lineages, or sublineages contributed to an increase in outbreaks in the months surrounding these events, and the same was observed when Kurban Bayramı festivities occurred. Although Türkiye has made progress in reducing the FMD burden, the emergence of new serotypes highlights the ongoing risk of serotype diversification and underscores the need for adaptable, serotype-specific surveillance, and control strategies. Strengthening early detection systems, maintaining high vaccine coverage, and fostering regional cooperation remain essential for sustainable FMD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.